Every frontier AI lab and pharma company is about to scale compute spend in drug discovery
The big opportunity for startups will be in the infrastructure and data bottleneck: toxicology, preclinical development, new trial design, new data collection, regulatory, CMC, RWE, etc
Anthropic says it's getting into the drug development business (?). The company will focus on discovering drugs for "neglected" diseases. TBD what it'll do if it finds any promising drug candidates https://t.co/ly7WKHMUsh
@pitdesi If it’s so cheap it’s probably already written off by the lender and so hopefully they’re getting it removed from people’s credit (otherwise there’s little value because the lender already wrote it off)
SpaceX has exercised the option to acquire @cursor_ai in an all-stock transaction with the goal of building the world’s most useful AI models.
For the past few months, SpaceXAI has been jointly training a model with Cursor, which will be released in Cursor and Grok Build soon.
We look forward to working closely with the Cursor team to advance our frontier AI capabilities
The infra behind this is Gigs (YC W21).
They’ve spent years quietly rebuilding the telecom carrier stack: connectivity, billing, compliance, support, ops.
Now companies like Block can launch mobile plans inside the products people already trust.
Telecom is becoming programmable.